Skip to content

Influence of a vegan diet on immunological parameters related to rheumatoid arthritis in healthy volunteers – a randomised controlled trial

Influence of a vegan diet on immunological parameters related to rheumatoid arthritis in healthy volunteers – a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011963
Enrollment
52
Registered
2017-03-30
Start date
2017-04-11
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory parameters, redox status and microbiome. Healthy volunteers

Interventions

Group 1: Vegan diet for 4 weeks: The volunteers in this arm should emphasise a variety of plant foods and should not consume any animal products (e.g. dairy products, meat, fish, eggs or honey). Seve

Sponsors

Universitätsklinikum Freiburg, Institut für Umweltmedizin und Krankenhaushygiene, Uni-Zentrum Naturheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: healthy, 18 - 60 years old, body mass index (BMI) between 21 kg/m^2 and 30 kg/m^2

Exclusion criteria

Exclusion criteria: pregnany and breastfeeding; regular intake of medication (except contraceptives or iodide); pronounced allergies (medication needed during allergy season); momentarily adhering to a vegan or vegetarian diet; aversion towards a meat-rich or vegan diet; eating disorder (anamnestically); drug, alcohol (>20g / day) or nicotine abuse (daily use), participation in another study or blood donation during the last four weeks.

Design outcomes

Primary

MeasureTime frame
metabolic function of B-cells, measured by the sialylation of anti-bodies; count of regulatory T-cells, measured by the concentration of FoxP3; serum-concentration of Interleukin 10; redox status of immune cells, measured by the intracellular ROS-concentration In the beginning and in the end of the intervention we will take blood samples of all probands. Examination of the samples will be done in the end.

Secondary

MeasureTime frame
- CCR6, a chemokine-receptor on TH-17 cells - Neopterin, a marker of macrophages-activity - I?Ba-degradation - serum antibodies with galactosyl attachments - serum free light chains (? and ?) - serum IL-1, IL-6, IL-17, IL-20, IL-24, IL-27, TNF-a, TNF-ß, soluble IL-2 receptor - arachidonic acid and eicosanoids in urine - autophagy-markers (Atg8/LC3) - lymphocytes differentiation o activated T-cells: CD3+/HLA-DR+ o activated B-cells: CD19+/CD71+ (transferrin receptor) o natural regulatory T-cells: CD3+/CD4+/CD25+/CD127 low - differential blood count - Vitamin D (25(OH)D), Vitamin B12 (transcobalamin II) - Microbiological profile of gut flora - genome-wide methylation analysis - gene expression of cyclooxygenase in lymphocytes in peripheral blood In the beginning and in the end of the intervention we will collect samples of urine, stool and blood of all probands. Examination of the samples will be done in the end.

Countries

Germany

Contacts

Public ContactManuel Hettich

Universitätsklinikum Freiburg, Institut für Umweltmedizin und Krankenhaushygiene, Uni-Zentrum Naturheilkunde

manuel.hettich@uniklinik-freiburg.de+49 761 270 82 01 0

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 28, 2026